A.R.T. Advisors’s Tenax Therapeutics TENX Stock Holding History

A.R.T. Advisors’s Portfolio TENX Stock Details TENX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-6	Closed	-$12K	–	1710
2019 Q3	$12K	Buy	+6	New	+$12.5K	﹤0.01%	1384

Other funds holding TENX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

FWP

FAS Wealth Partners Leawood, Kansas $1.61B AUM 19.97% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

A.R.T. Advisors's TENX Position: Q4 2019 in Review

A.R.T. Advisors sold out of Tenax Therapeutics (TENX) in Q4 2019, closing a stake of 6 shares — an estimated $12K sold.

A.R.T. Advisors first reported a position in TENX in Q3 2019 and held it in 1 quarter. The position peaked at $12K in Q3 2019. 10 funds tracked by Wall St. Rank hold TENX as of Q4 2019.

A.R.T. Advisors reported no remaining Tenax Therapeutics position as of Q4 2019 after selling out during the quarter.
A.R.T. Advisors sold 6 Tenax Therapeutics shares in Q4 2019, an estimated $12K.
A.R.T. Advisors first reported a position in Tenax Therapeutics in Q3 2019 and held it in 1 quarter.
A.R.T. Advisors's Tenax Therapeutics position peaked at $12K in Q3 2019.
10 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q4 2019.

Based on A.R.T. Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.